Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase ZNRF1 is an enzyme containing both a zinc finger and a RING finger motif, functioning as a RING-type E3 ubiquitin ligase highly expressed in the nervous system and other tissues[1][5][7]. ZNRF1 catalyzes the transfer of ubiquitin to substrate proteins, marking them for degradation by the proteasome or modulating their signaling functions. In neurons, it localizes primarily to synaptic vesicle membranes and participates in regulating neuronal transmission, synaptic plasticity, and neurite outgrowth[1][2]. ZNRF1 is implicated in processes such as neural development, axonal degeneration, and the neuroimmune response, partly by modulating signaling molecules like AKT1, EGFR, and caveolin-1[5]. It controls inflammation by regulating degradation of caveolin-1 and modulates Toll-like receptor 4 (TLR4)-mediated immune signaling; loss or dysfunction of ZNRF1 can suppress pro-inflammatory cytokine production and protect against sepsis in animal models[3][5]. ZNRF1 may also play a role in Schwann cell differentiation and is upregulated following nerve injury, suggesting a role in nerve regeneration and degeneration[1][5]. No clinical drugs officially target ZNRF1, but its activity affects pathways relevant to neurodegeneration, inflammation, and cellular homeostasis.
Ubiquitination of substrate proteins leading to their proteasomal degradation or altered cellular signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin-protein ligase ZNRF1 (ZNRF1).